Roivant Sciences Ltd. · NASDAQ:ROIV
Sukhatme Mayukh sold 335,174 Roivant Sciences Ltd. shares (Form 4)
Traded Aug 19 to Aug 21, 2026 · Filed Aug 21, 2026
From Aug 19 to Aug 21, 2026, Sukhatme Mayukh (Director, President & CIO) sold 335,174 Roivant Sciences Ltd. shares at an average US$36.88 for US$12.4M, leaving 18,630,739 shares. Filed Aug 21, 2026 (Form 4).
- Sold
- 335,174 shares
- Price
- US$36.88 average (US$36.48 to US$37.30)
- Value
- US$12.4M
- Holding after
- 18,630,739 shares
- Trading plan
- No
- Role
- Director, President & CIO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Common Shares | Option exercise | 172,899 | US$3.85 | 18,803,638 | Direct |
| Aug 19, 2026 | Common Shares | Sale | 172,899 | US$37.17 | 18,630,739 | Direct |
| Aug 20, 2026 | Common Shares | Option exercise | 17,519 | US$3.85 | 18,648,258 | Direct |
| Aug 20, 2026 | Common Shares | Sale | 17,519 | US$37.30 | 18,630,739 | Direct |
| Aug 21, 2026 | Common Shares | Option exercise | 144,756 | US$3.85 | 18,775,495 | Direct |
| Aug 21, 2026 | Common Shares | Sale | 144,756 | US$36.48 | 18,630,739 | Direct |
Source
Related
- Roivant Sciences Ltd.
- Sukhatme Mayukh
- Roivant Sciences Ltd. shareholders
- Form 4 · Sukhatme Mayukh · Oct 2, 2026
- Form 4 · Sukhatme Mayukh · Aug 18, 2026
- Form 4 · Sukhatme Mayukh · Jul 2, 2026
- Form 4 · Sukhatme Mayukh · Jun 29, 2026
- Form 4 · Sukhatme Mayukh · Apr 1, 2026
- Form 4 · Epperly Melissa B, · Oct 5, 2026
- Form 4 · Gline Matthew · Oct 2, 2026
- Form 4 · Venker Eric · Oct 2, 2026
- Form 4 · Torti Frank · Oct 2, 2026
- Form 4 · Pulik Richard · Sep 22, 2026